XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (18,892) $ (13,109)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,563 1,409
Stock-based compensation 5,928 5,079
Provision for bad debts 1,051 188
Amortization of operating lease right-of-use assets 263 148
Amortization of debt discount and issuance costs 301 277
Deferred income taxes (5) 5
Revaluation of contingent royalty obligation payable to Evolus Founders 2,151 1,578
Other 146 0
Changes in assets and liabilities:    
Inventories 4,050 5,309
Accounts receivable (823) (3,899)
Prepaid expenses (103) 22
Accounts payable 4,722 909
Accrued expenses (14,172) (8,874)
Operating lease liabilities (79) (171)
Other assets (1,733) 514
Net cash used in operating activities (15,632) (10,615)
Cash flows from investing activities    
Purchases of property and equipment (319) (256)
Additions to capitalized software (1,542) (541)
Net cash used in investing activities (1,861) (797)
Cash flows from financing activities    
Payment of contingent royalty obligation to Evolus Founders (2,365) (1,829)
Proceeds from follow-on offering, net of underwriters fees 0 47,004
Issuance of common stock in connection with incentive equity plan 742 487
Tax withholding paid on behalf of employees for stock-based awards (8) 0
Net cash provided by (used in) financing activities (1,631) 45,662
Effect of exchange rates on cash 66 (130)
Change in cash and cash equivalents (19,058) 34,120
Cash and cash equivalents, beginning of period 86,952 62,838
Cash and cash equivalents, end of period 67,894 96,958
Supplemental disclosure of cash flow information    
Cash paid for interest 4,056 4,424
Cash paid for income taxes 46 26
Non-cash investing and financing information    
Accrued offering costs, unpaid $ 0 $ 210